In patients with biochemically defined defects affecting multiple mitochondrial respiratory chain complexes (enzymes that are involved in basic energy production), use of exome sequencing improved the ability to identify the underlying gene mutations.
This is according to a study in the July 2 issue of JAMA. Defects of the mitochondrial respiratory chain have emerged as the most common cause of childhood and adult neurometabolic disease, with an estimated prevalence of l in 5,000 live births.
Gene Mutations Could Protect Against Heart Disease
The risk of heart disease could be cut by 40 percent with a rare set of genetic mutations found in fewer than one percent of the population, researchers said Wednesday.
Advertisement
Clinically these disorders can present at any time of life, are often seen in association with neurological impairment, and cause chronic disability and premature death. The diagnosis of mitochondrial disorders remains challenging, according to background information in the article. Examples of problems caused by mitochondrial diseases include a type of epilepsy; mitochondrial encephalopathy; lactic acidosis; and a syndrome that includes stroke-like episodes.
Robert W. Taylor, Ph.D., F.R.C.Path., of Newcastle University, Newcastle upon Tyne, U.K., and colleagues studied whether a whole-exome sequencing approach could help define the molecular basis of mitochondrial disease. Whole-exome sequencing is a complex laboratory process that determines the entire unique sequence of an organism's exome (the collection of exons, which are relatively small lengths of a whole genome and contain instructions for the body to build proteins).
![Women With a Specific Gene Mutation Face Higher Risk of Dying from a Type of Breast Cancer]( "Women With a Specific Gene Mutation Face Higher Risk of Dying from a Type of Breast Cancer")
New study reveals women with a specific gene mutation have a higher risk of dying from a type of breast cancer. The study raises the prospects of targeted drugs.
The study included 53 patients, referred to 2 national centers in the United Kingdom and Germany between 2005 and 2012, who had biochemical evidence of multiple respiratory chain complex defects. The majority (51/53 [96 percent]) of the patients presented during childhood (<15 years old) and most (66 percent) developed symptoms within the first year of life. The most frequent clinical features were muscle weakness, central neurological disease, cardiomyopathy, and abnormal liver function; a combination of these abnormalities was present in most cases.
Following whole-exome sequencing, presumptive causal variants were identified in 28 patients (53 percent) and possible causal variants were identified in 4 (8 percent). Together these accounted for 32 patients (60 percent) and involved 18 different genes. Distinguishing clinical features included deafness and kidney involvement associated with one gene, and cardiomyopathy with two genes. In 20 patients with prominent heart disease, the causative mutation was detected in 80 percent, while the detection rate was much lower in patients with liver disease (33 percent). It was not possible to confidently identify the underlying genetic basis in 21 patients (40 percent).
"In the pre-exome era, the systematic biochemical characterization of 53 patients with multiple respiratory chain complex defects led to detection of the underlying genetic basis in only 1 patient. The work presented herein demonstrates the effect of whole-exome sequencing in this context, which has defined the genetic etiology in 32 of 53 patients (60 percent) with a confirmed biochemical defect," the authors write. "Our findings contrast with large-scale candidate gene analysis using conventional and next-generation sequencing approaches, both of which had a lower diagnostic yield (10 percent-13 percent) and by definition did not discover new potential disease genes."
"Additional study is required to determine the utility of this approach compared with traditional diagnostic methods in independent patient populations," the researchers conclude.
Source: Newswise
Women With a Specific Gene Mutation Face Higher Risk of Dying from a Type of Breast Cancer
New study reveals women with a specific gene mutation have a higher risk of dying from a type of breast cancer. The study raises the prospects of targeted drugs.
Advertisement
The study included 53 patients, referred to 2 national centers in the United Kingdom and Germany between 2005 and 2012, who had biochemical evidence of multiple respiratory chain complex defects. The majority (51/53 [96 percent]) of the patients presented during childhood (<15 years old) and most (66 percent) developed symptoms within the first year of life. The most frequent clinical features were muscle weakness, central neurological disease, cardiomyopathy, and abnormal liver function; a combination of these abnormalities was present in most cases.
Following whole-exome sequencing, presumptive causal variants were identified in 28 patients (53 percent) and possible causal variants were identified in 4 (8 percent). Together these accounted for 32 patients (60 percent) and involved 18 different genes. Distinguishing clinical features included deafness and kidney involvement associated with one gene, and cardiomyopathy with two genes. In 20 patients with prominent heart disease, the causative mutation was detected in 80 percent, while the detection rate was much lower in patients with liver disease (33 percent). It was not possible to confidently identify the underlying genetic basis in 21 patients (40 percent).
"In the pre-exome era, the systematic biochemical characterization of 53 patients with multiple respiratory chain complex defects led to detection of the underlying genetic basis in only 1 patient. The work presented herein demonstrates the effect of whole-exome sequencing in this context, which has defined the genetic etiology in 32 of 53 patients (60 percent) with a confirmed biochemical defect," the authors write. "Our findings contrast with large-scale candidate gene analysis using conventional and next-generation sequencing approaches, both of which had a lower diagnostic yield (10 percent-13 percent) and by definition did not discover new potential disease genes."
"Additional study is required to determine the utility of this approach compared with traditional diagnostic methods in independent patient populations," the researchers conclude.
Source: Newswise
Elevated Liver Values in Children is a Combination of Overweight and Gene Mutation
A common mutation in the PNPLA3 gene in combination with overweight results in an elevated ALAT values in children, shows a study carried out at the Institute of Biomedicine.
Advertisement
 Brain Disorders in Children Explained With Gene Mutation DiscoveryMutations in one of the brain's key genes could be responsible for impaired mental function in children born with intellectual disability, discovered researchers. | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
Is there a link between epilepsy and Alzheimer's disease? Yes, certain genes associated with Alzheimer's disease may increase the risk of developing epilepsy.
More research is needed to understand the risks of hypnotics among COPD patients and then optimize treatment strategies.
Among hemorrhage patients, combination treatment protocol compared to usual care reduced poor functional outcomes.
Life stressors were found to lead to multiple sclerosis, revealed study.
Diet containing increased amounts of sugar may interrupt the function of resident intestinal stem cells (ISCs) that maintain gut lining after inflammatory damage.